1. Mundell, Stuart James, Mumford, Andrew. 2018. TBXA2R gene variants associated with bleeding. In Platelets, 29, 739-742. doi:10.1080/09537104.2018.1499888. https://pubmed.ncbi.nlm.nih.gov/30089223/
2. Kim, J-H, Lee, S-Y, Kim, H-B, Jang, S-O, Hong, S-J. 2007. TBXA2R gene polymorphism and responsiveness to leukotriene receptor antagonist in children with asthma. In Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 38, 51-9. doi:. https://pubmed.ncbi.nlm.nih.gov/18031559/
3. Kavalar, M S, Balantic, M, Silar, M, Korosec, P, Rijavec, M. 2011. Association of ORMDL3, STAT6 and TBXA2R gene polymorphisms with asthma. In International journal of immunogenetics, 39, 20-5. doi:10.1111/j.1744-313X.2011.01051.x. https://pubmed.ncbi.nlm.nih.gov/22017802/
4. Ganai, Indranil, Saha, Ishita, Banerjee, Priyajit, Moitra, Saibal, Podder, Sanjoy. 2023. In silico analysis of single nucleotide polymorphism (rs34377097) of TBXA2R gene and pollen induced bronchial asthma susceptibility in West Bengal population, India. In Frontiers in immunology, 14, 1089514. doi:10.3389/fimmu.2023.1089514. https://pubmed.ncbi.nlm.nih.gov/36936944/
5. Forgerini, Marcela, Gini, Ana Luísa Rodriguez, Lemos, Isabele Held, Valentini, Sandro Roberto, Mastroianni, Patrícia de Carvalho. 2024. The Impact of TBXA2R Gene Variants on the Risk of Aspirin-Induced Upper Gastrointestinal Bleeding: A Case-Control Study. In Hospital pharmacy, 59, 666-676. doi:10.1177/00185787241269111. https://pubmed.ncbi.nlm.nih.gov/39465093/
6. Palikhe, N S, Kim, S-H, Lee, H-Y, Ye, Y-M, Park, H-S. 2010. Association of thromboxane A2 receptor (TBXA2R) gene polymorphism in patients with aspirin-intolerant acute urticaria. In Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 41, 179-85. doi:10.1111/j.1365-2222.2010.03642.x. https://pubmed.ncbi.nlm.nih.gov/21070398/
7. Orr, Katy, Buckley, Niamh E, Haddock, Paula, McQuaid, Stephen, Mullan, Paul B. . Thromboxane A2 receptor (TBXA2R) is a potent survival factor for triple negative breast cancers (TNBCs). In Oncotarget, 7, 55458-55472. doi:10.18632/oncotarget.10969. https://pubmed.ncbi.nlm.nih.gov/27487152/